 bypass. Arch Surg 1982;117:1580-8.
170. Brewster DC. Current controversies in the management of aortoiliac
occlusive disease. J Vasc Surg 1997;25:365-79.

38S Conte and Pomposelli et al

171. Malone JM, Moore WS, Goldstone J. Life expectancy following
aortofemoral arterial grafting. Surgery 1977;81:551-5.
172. Morris GC Jr, Edwards E, Cooley DA, Crawford ES, De Bakey ME.
Surgical importance of profunda femoris artery. Analysis of 102 cases
with combined aortoiliac and femoropopliteal occlusive disease
treated by revascularization of deep femoral artery. Arch Surg
1961;82:32-7.
173. Inahara T. Evaluation of endarterectomy for aortoiliac and aortoiliofemoral occlusive disease. Arch Surg 1975;110:1458-64.
174. Stoney RR, Reilly LM Current therapy in vascular therapy. In:
Ernst C, Stanley JC, editors. Endarterectomy for aortoiliac occlusive
disease. Philadelphia: BC Decker; 1987.
175. Ricco JB, Probst H; French University Surgeons Association. Longterm results of a multicenter randomized study on direct versus
crossover bypass for unilateral iliac artery occlusive disease. J Vasc Surg
2008;47:45-53; discussion: 53-4.
176. Cham C, Myers KA, Scott DF, Devine TJ, Denton MJ. Extraperitoneal unilateral iliac artery bypass for chronic lower limb ischaemia.
Aust N Z J Surg 1988;58:859-63.
177. Melliere D, Desgranges P, de Wailly GW, Roudot-Thoraval F,
Allaire E, Becquemin JP. Extensive unilateral iliofemoral occlusions:
durability of four techniques of arterial reconstructions